Date
The European Investment Bank (EIB) is lending EUR 24 million to F2G Biotech, a research-intensive company in Austria, focusing on the discovery and development of novel drugs to treat life threatening fungal diseases.
Read full text
Change text size
- Plain text
- Medium text
- Enlarged text
Color contrast
- Black and white
- High contrast
- Normal contrast
Display
- Large white cursor
- Large black cursor
- Highlight links
- Disable accessibility
- Declaration of Accessibility
